Has Vijay Subramanian, MD received payments from drug or device companies?

Yes. Drug and device makers reported $21,626 in general payments to Vijay Subramanian, MD across 44 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Vijay Subramanian, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Vijay Subramanian, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Vijay Subramanian, MD

Transplant Surgery · Tampa, FLNPI 1932549359

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (32.9%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Organox Ltd accounts for 85.9% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $10,302, more than ten times the $96 reported in 2019. Among transplant surgery clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$21,626in general payments, 2019–2025

Across 44 payments — averaging $491.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Organox Ltd$19K
Intuitive Surgical$2K
Baxter Healthcare$386
Veloxis Pharmaceuticals, Inc.$383
Boston Scientific$269
La Jolla Pharmaceutical Company$163
plus $346 from 4 others

$921,043in research payments, 2019–2025

Across 88 payments — averaging $10,466 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Organox Ltd$623K
Modernatx, Inc.$298K

What the payments were for

Consulting fees$3,72417%
Speaking & faculty fees$7,12333%
Travel & lodging$6,28529%
Food & beverage$2,72113%
Education$1,5907%
Gifts$1831%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Organox Ltd	24	$18,575
Intuitive Surgical	2	$1,503
Baxter Healthcare	4	$386
Veloxis Pharmaceuticals, Inc.	7	$383
Boston Scientific	2	$269
La Jolla Pharmaceutical Company	1	$163
Integra Lifesciences Corporation	1	$154
Jazz Pharmaceuticals Inc.	1	$90
Paragonix Technologies, Inc.	1	$80
Electromed, Inc.	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

METRA$18,375
DAVINCI XI$1,500
INTEGRA$308
TISSEEL$240
GIAPREZA$163
OMNIGRAFT$154
SURGIMEND$154
INTEGRA DERMAL REGENERATION TEMPLATE$154
TheraSphere Y90 Glass Microspheres 10 GBq$149
Renal - Acute$139
THERASPHERE$120

How this compares

$21,626 in reported general payments places this provider in the 90th percentile of 53 transplant surgery providers in Florida.

See all transplant surgery providers in Florida →

Medicare billing

Part B allowed, 2024

$140,399

Medicare patients

Services billed

156

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
LokelmaSodium Zirconium Cyclosilicate	56	$53,549
Envarsus XrTacrolimus	13	$14,931
Valganciclovir Hcl	56	$8,101
Ursodiol	33	$3,177
Mycophenolate Mofetil	12	$343
Bumetanide	13	$277
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	68	$256
Gabapentin	19	$239
Pantoprazole Sodium	21	$129
Amlodipine Besylate	18	$92
Carvedilol	14	$61
Prednisone	14	$61
Furosemide	16	$48
Single Use SwabAlcohol Antiseptic Pads	18	$40

Paid to pharmacies, not to this prescriber.

Other transplant surgery in Tampa

Amy LuTampa$133K
Eduardo AlsinaTampa$121K
Kiran DhanireddyTampa$40K
Ting HuangTampa$8K
Anthony WatkinsTampa$6K
Heidi PearsonTampa$6K
Marian PorubskyTampa$5K
Rachel HogenTampa$4K
Matthew WittTampa$4K
Abhishek MathurTampa$881

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →